H.B. Fuller surges 6.5% after earnings beat, guidance raise
Margin expansion from restructuring offsets organic sales decline, lifting full-year outlook
H.B. Fuller shares surged 6.5% to $56.71 in extended trading Wednesday after the adhesives manufacturer reported first-quarter results that exceeded earnings expectations and raised its full-year outlook, despite falling short on revenue. The Minnesota-based company's stock jumped on roughly double its average daily volume as investors focused on improving profitability rather than the top-line miss.
The company reported adjusted earnings per share of 57 cents for the quarter ended February 28, beating the 56-cent consensus estimate. Net revenue of $771 million missed analyst projections, with organic sales declining 6.6% year-over-year. However, adjusted EBITDA increased 4% to $119 million, with the margin expanding 90 basis points to 15.4%.
The margin improvement tells a more compelling story than the revenue headline. Adjusted gross profit margin reached 31.3%, up 170 basis points from the prior year, driven by savings from the company's 'Quantum Leap' restructuring program alongside strategic pricing actions and acquisition benefits. The restructuring initiative targets $75 million in annual cost savings through facility consolidation and warehouse footprint reduction.
Encouraged by the improving profitability, management lifted its fiscal 2026 adjusted EPS guidance to a range of $4.55 to $4.90, with the midpoint of $4.73 exceeding the prior analyst consensus of $4.52. The company also projects adjusted EBITDA of $645 million to $675 million for the full year.
[The earnings beat and guidance increase] drew an immediate positive reaction from Wall Street,” according to MarketBeat coverage, with the stock rallying 6.6% to $56.73 in Thursday's session. Analysts maintain an average price target of $70.43, representing roughly 24% upside from current levels, with ratings split between buy and hold recommendations.
H.B. Fuller, which manufactures adhesives, sealants, coatings and specialty chemicals worldwide, faces ongoing volume headwinds in an industrial environment characterized by cautious customer spending. The 6.6% organic sales decline reflects broader softness in manufacturing demand, particularly in markets sensitive to interest rates and economic uncertainty.
However, the company's ability to expand margins while managing through volume pressure demonstrates the effectiveness of its operational efficiency initiatives. The restructuring program appears to be delivering on promised cost savings at an accelerated pace, allowing pricing discipline to flow through to the bottom line even as volumes contract.
The divergence between the company's performance and broader market sentiment is evident in its valuation metrics. H.B. Fuller trades at a forward price-to-earnings ratio of 10.7 times, significantly below its trailing multiple of 19.4 times, suggesting investors are awaiting sustained evidence that the margin improvements will continue despite near-term volume challenges.
With $2.9 billion in market capitalization and institutional ownership exceeding 100% due to short interest, the stock remains closely watched by portfolio managers. The 52-week range spans $46.81 to $68.63, leaving room for recovery should the company execute on its full-year guidance and deliver the projected margin expansion.
Investors will focus on upcoming quarters for evidence that the Quantum Leap restructuring benefits are sustainable and that organic volume decline stabilizes. Management's confidence in raising guidance despite persistent volume pressure signals conviction in the company's pricing power and cost discipline—critical attributes in a slowing industrial cycle.